Total Payments
$1,107
2020 Payments
$256.61
Companies
11
Transactions
19
Medicare Patients
3,347
Medicare Billing
$318,778
Payment Breakdown by Category
Food & Beverage$1,107 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,107 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $270.34 | 4 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $143.07 | 4 | $0 (2020) |
| La Jolla Pharmaceutical Company | $121.69 | 2 | $0 (2020) |
| Valeant Pharmaceuticals North America LLC | $114.02 | 2 | $0 (2017) |
| Melinta Therapeutics, Inc. | $105.18 | 1 | $0 (2019) |
| The Medicines Company | $93.74 | 1 | $0 (2017) |
| BTG INTERNATIONAL, INC. | $89.32 | 1 | $0 (2020) |
| Philips Electronics North America Corporation | $79.49 | 1 | $0 (2018) |
| Chiesi USA, Inc. | $60.39 | 1 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $17.08 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $256.61 | 6 | BTG INTERNATIONAL, INC. ($89.32) |
| 2019 | $266.94 | 4 | AstraZeneca Pharmaceuticals LP ($118.63) |
| 2018 | $218.70 | 4 | Philips Electronics North America Corporation ($79.49) |
| 2017 | $364.30 | 5 | E.R. Squibb & Sons, L.L.C. ($156.54) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/10/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/24/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/06/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/12/2020 | BTG INTERNATIONAL, INC. | CROFAB (Drug) | Food and Beverage | Cash or cash equivalent | $89.32 | General |
| Category: ANTI-VENOM | ||||||
| 02/13/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $52.06 | General |
| Category: Cardiovascular | ||||||
| 01/09/2020 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $78.56 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 09/12/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $105.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/09/2019 | Melinta Therapeutics, Inc. | Orbactiv (Drug) | Food and Beverage | In-kind items and services | $105.18 | General |
| Category: ANTIBIOTICS | ||||||
| 03/25/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/10/2019 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $43.13 | General |
| Category: GIAPREZA | ||||||
| 12/03/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/13/2018 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $60.39 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/12/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $61.74 | General |
| Category: Cardiovascular | ||||||
| 02/08/2018 | Philips Electronics North America Corporation | IGT_D Peripheral (Device) | Food and Beverage | Cash or cash equivalent | $79.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/11/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $99.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/16/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/13/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $58.49 | General |
| Category: Cardiovascular | ||||||
| 04/12/2017 | The Medicines Company | MINOCIN IV (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $93.74 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/08/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $98.05 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,163 | 1,188 | $577,996 | $106,857 |
| 2022 | 8 | 1,155 | 1,183 | $575,311 | $104,453 |
| 2021 | 6 | 668 | 706 | $866,591 | $70,020 |
| 2020 | 5 | 361 | 366 | $523,124 | $37,448 |
Total Patients
3,347
Total Services
3,443
Medicare Billing
$318,778
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 177 | 180 | $197,934 | $35,927 | 18.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 194 | 198 | $132,858 | $31,112 | 23.4% |
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 152 | 153 | $142,600 | $22,438 | 15.7% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 91 | 93 | $59,427 | $9,362 | 15.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 324 | 339 | $17,967 | $2,455 | 13.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $9,557 | $2,231 | 23.3% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 21 | 21 | $9,513 | $2,229 | 23.4% |
| 93042 | Electrocardiogram (ecg) 1 to 3 leads with review by physician only | Facility | 2023 | 185 | 185 | $8,140 | $1,103 | 13.6% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 277 | 285 | $267,670 | $45,363 | 16.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 132 | 134 | $147,334 | $30,103 | 20.4% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 73 | 74 | $62,234 | $13,212 | 21.2% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 80 | 81 | $51,461 | $8,009 | 15.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 342 | 351 | $18,603 | $2,547 | 13.7% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 19 | 20 | $9,060 | $2,323 | 25.6% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 28 | 29 | $9,753 | $1,670 | 17.1% |
| 93042 | Electrocardiogram (ecg) 1 to 3 leads with review by physician only | Facility | 2022 | 204 | 209 | $9,196 | $1,228 | 13.4% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 307 | 333 | $668,120 | $54,012 | 8.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 36 | 36 | $77,706 | $7,313 | 9.4% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 55 | 55 | $73,028 | $5,634 | 7.7% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 198 | 209 | $21,241 | $1,418 | 6.7% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 26 | 26 | $24,428 | $1,350 | 5.5% |
| 93042 | Interpretation and report of electrical activity of heart using 1-3 leads | Facility | 2021 | 46 | 47 | $2,068 | $292.81 | 14.2% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 166 | 168 | $355,914 | $24,850 | 7.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 25 | 26 | $63,386 | $5,657 | 8.9% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 49 | 49 | $65,700 | $4,587 | 7.0% |
About Dr. Myles Fisher, D.O
Dr. Myles Fisher, D.O is a Emergency Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2016. The National Provider Identifier (NPI) number assigned to this provider is 1407208333.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Myles Fisher, D.O has received a total of $1,107 in payments from pharmaceutical and medical device companies, with $256.61 received in 2020. These payments were reported across 19 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,107).
As a Medicare-enrolled provider, Fisher has provided services to 3,347 Medicare beneficiaries, totaling 3,443 services with total Medicare billing of $318,778. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Oklahoma City, OK
- Active Since 07/03/2016
- Last Updated 12/21/2021
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1407208333
Products in Payments
- ELIQUIS (Drug) $270.34
- LOKELMA (Drug) $143.07
- GIAPREZA (Drug) $121.69
- XIFAXAN (Drug) $114.02
- Orbactiv (Drug) $105.18
- MINOCIN IV (Drug) $93.74
- CROFAB (Drug) $89.32
- IGT_D Peripheral (Device) $79.49
- CLEVIPREX (Drug) $60.39
- XARELTO (Drug) $17.08
- RELISTOR (Drug) $12.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Oklahoma City
Alexander Frank, M.d, M.D
Emergency Medicine — Payments: $3.1M
Emergency Medicine $3.1M
Mohammad Razaq, M.d, M.D
Emergency Medicine — Payments: $177,813
Emergency Medicine $177,813
Jose Borrego Acosta, Md, MD
Emergency Medicine — Payments: $76,213
Emergency Medicine $76,213
Lindsey Epperson
Emergency Medicine — Payments: $36,931
Emergency Medicine $36,931
Dr. Tyson Quy, M.d, M.D
Emergency Medicine — Payments: $35,983
Emergency Medicine $35,983
Michael Partin, M.d, M.D
Emergency Medicine — Payments: $10,117
Emergency Medicine $10,117